Compounds > declopramide
Page last updated: 2024-08-25

declopramide and procainamide

declopramide has been researched along with procainamide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hua, J; Pero, RW1
Hua, J; Kane, R; Pero, RW1
Ivars, F; Leanderson, T; Lindgren, H; Pero, RW1
Leanderson, T; Lindgren, H; Olsson, AR; Pero, RW2

Other Studies

5 other study(ies) available for declopramide and procainamide

ArticleYear
Toxicity, antitumor and chemosensitizing effects of 3-chloroprocainamide.
    Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:8

    Topics: Animals; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Female; Humans; Male; Metoclopramide; Mice; Mice, SCID; Neoplasm Transplantation; Procainamide; Transplantation, Heterologous

1997
Pharmacokinetics and central nervous system toxicity of declopramide (3-chloroprocainamide) in rats and mice.
    Anti-cancer drugs, 1999, Volume: 10, Issue:1

    Topics: Administration, Oral; Animals; Antiemetics; Biological Availability; Central Nervous System; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Metoclopramide; Mice; Mice, SCID; Procainamide; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Sleep Stages; Tissue Distribution

1999
N-substituted benzamides inhibit nuclear factor-kappaB and nuclear factor of activated T cells activity while inducing activator protein 1 activity in T lymphocytes.
    Molecular immunology, 2001, Volume: 38, Issue:4

    Topics: Acecainide; Benzamides; CD40 Ligand; Cell Nucleus; DNA-Binding Proteins; Enzyme Activation; Humans; Interleukin-2; Jurkat Cells; NF-kappa B; NF-kappa B p50 Subunit; NFATC Transcription Factors; Nuclear Proteins; Procainamide; Promoter Regions, Genetic; T-Lymphocytes; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic

2001
Mechanism of action for N-substituted benzamide-induced apoptosis.
    British journal of cancer, 2002, Mar-18, Volume: 86, Issue:6

    Topics: Apoptosis; Benzamides; Caspase 9; Caspases; Cytochrome c Group; Enzyme Activation; G2 Phase; HL-60 Cells; Humans; Metoclopramide; Mitosis; Procainamide; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53

2002
Differential usage of IkappaBalpha and IkappaBbeta in regulation of apoptosis versus gene expression.
    Biochemical and biophysical research communications, 2003, Jan-31, Volume: 301, Issue:1

    Topics: Animals; Apoptosis; B-Lymphocytes; Cell Line; Flow Cytometry; Gene Expression Regulation; I-kappa B Proteins; Immunoglobulins; Lipopolysaccharides; Mice; Molecular Structure; NF-kappa B; NF-KappaB Inhibitor alpha; Procainamide; Proto-Oncogene Proteins c-bcl-2

2003